InvestorsHub Logo

DewDiligence

07/16/19 10:56 AM

#225585 RE: DewDiligence #225581

ABUS—(-6%)—addendum: When a company’s clinical program goes from testing in patients to testing in healthy volunteers, that’s generally not a good sign!